Zhu Wenchen, the first richest man in Henan and the actual controller of Furen Pharmaceuticals, was suspected of illegal information disclosure, and was previously filed by the China Securities Regulatory Commission to investigate.
A number of media in China reported the above news on Saturday (May 20).Zhu Wenchen founded Fu Ren Pharmaceutical in 1995, and then became a "capital giant" that spans the two major stock markets of medicine and liquor through mergers and acquisitions.The company's market value was nearly 15 billion yuan (RMB, the same below, about S $ 2.9 billion), and Zhu Wenchen has also become the richest man in Henan many times.
The announcement issued by Fu Ren Pharmaceutical on May 9 showed that Zhu Wenchen had been filed by the China Securities Regulatory Commission's inspection team on April 3.But as of the announcement date, the Inspection Corps has not contacted Zhu Wenchen.
According to the WeChat public account "Red Star Capital Bureau" under the Red Star News, the company's shares have been suspended from May 4 due to the negative value of the audited net assets in 2022.The Shanghai Stock Exchange will make a decision to terminate whether the company's stock listing will be terminated within 15 trading days after the company's stock suspension.
Annual report shows that the revenue of Furen Pharmaceutical in 2022 was about 1.469 billion yuan, a decrease of 2.9%year -on -year, and a loss of over 2.8 billion yuan.
According to the Daily Economic News report, the company currently has multiple executive information, and the total execution amount exceeds 2.95 billion yuan.In addition, there are still many dishonestyes, restricting consumption orders, and final case information, and have not fulfilled the amount of over 1.28 billion yuan.
